Mon, Jul 28, 2014, 3:15 AM EDT - U.S. Markets open in 6 hrs 15 mins

Recent

% | $
Click the to save as a favorite.

Amarin Corporation plc Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • mtdsus mtdsus Nov 20, 2012 9:51 AM Flag

    FORBES ARTICLE makes strong case for "CO-MARKETING AGREEMENT"

    Forbes writer Matthew--is a very incompetent Journalist.
    1) He says--Jelis was only one study that proved its effectiveness for reducing Cardiac events.
    2) He never bothered to read the study--18,000 people studied for 6 years in Japan.
    3) He mingles product like Vascepa and Epadel with studies for Lovaza and Fish Oils that contain over 50% of DHA. EPA helps-DHA hurts Lipid profile. Lovaza may lower triglycerides but by raising LDL--most important Lipid profile--it causes problems with Heart.
    He wrote an article in 2008--"One Supplement that works"-he was refering to FISH OIL and LOVAZA-based on FAULTY STUDIES.

 
AMRN
1.50-0.07(-4.46%)Jul 25 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.